Compare $NEUP vs $VICP | Chartloom

Compare

$NEUP vs $VICP

Neuphoria Therapeutics Inc · Vicapsys Life Sciences Inc

NEUP

Neuphoria Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Compare $NEUP vs $VICP

Comparing Neuphoria Therapeutics Inc and Vicapsys Life Sciences Inc

NEUPNeuphoria Therapeutics Inc

VICPVicapsys Life Sciences Inc

NEUPNeuphoria Therapeutics Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.5%

YTD performance

-12.0%

52W performance

-81.7%

FCF yield

-68.1%

VICPVicapsys Life Sciences Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.3%

52W performance

-68.9%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NEUP

VICP

Detailed metrics comparison

NEUP

Neuphoria Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

NEUP$18M

VICP$18M

Enterprise Value

NEUP$-2M

VICP$18M

Price

NEUP$3.36

VICP$0.55

P/E Ratio

NEUPN/A

VICPN/A

P/S Ratio

NEUP15.45x

VICP0.00x

EV/Sales

NEUP-1.44x

VICP0.00x

EV/EBITDA

NEUP0.00x

VICP0.00x

P/B Ratio

NEUP0.76x

VICPN/A

P/FCF Ratio

NEUPN/A

VICPN/A

EV/FCF

NEUP0.14x

VICP0.00x

PEG Ratio

NEUPN/A

VICPN/A

Forward P/E (NTM)

NEUPN/A

VICPN/A

Forward P/S (NTM)

NEUPN/A

VICPN/A

Revenue (TTM)

NEUP$1M

VICP$0

Revenue Growth (YoY)

NEUP-92.5%

VICPN/A

Forward Rev Growth

NEUP0.0%

VICP0.0%

Gross Margin (TTM)

NEUP0.0%

VICP0.0%

Operating Margin (TTM)

NEUP0.0%

VICP0.0%

EBITDA Margin (TTM)

NEUP-779.0%

VICP0.0%

Net Margin (TTM)

NEUP-1145.6%

VICP0.0%

FCF Margin (TTM)

NEUP-1052.0%

VICPN/A

Net Income (TTM)

NEUP$-13M

VICPN/A

FCF (TTM)

NEUP$-12M

VICP$0

EPS (TTM)

NEUP-$2.49

VICP$0.00

ROE (TTM)

NEUP-5591.0%

VICP0.0%

ROA (TTM)

NEUP-4222.0%

VICP0.0%

ROIC (TTM)

NEUP-5583.0%

VICP0.0%

Cash

NEUP$20M

VICP$90K

Debt

NEUP$34K

VICP$579K

Net Cash/Debt

NEUP$20M

VICP$-489K

Current Ratio (TTM)

NEUP27.85x

VICP0.03x

Quick Ratio (TTM)

NEUP27.33x

VICP0.03x

Debt/Equity (TTM)

NEUP0.00x

VICP0.00x

Debt/Assets (TTM)

NEUP0.0%

VICP0.0%

Interest Coverage (TTM)

NEUPN/A

VICPN/A

Net Debt/EBITDA (TTM)

NEUP0.00x

VICP0.00x

Beta

NEUP0.76

VICP-3.98

52W Performance

NEUP-81.7%

VICP-68.9%

YTD Performance

NEUP-12.0%

VICP-63.3%

% from 52W High

NEUP-82.5%

VICP-68.9%

% from 52W Low

NEUP5.3%

VICP399.9%

Asset Turnover (TTM)

NEUP0.04x

VICP0.00x

FCF Yield (TTM)

NEUP-68.1%

VICP0.0%

Earnings Yield (TTM)

NEUP-74.1%

VICP0.0%

Dividend Yield (TTM)

NEUPN/A

VICPN/A

Rule of 40

NEUP-1,144.5

VICP0.0

EV/GP/RG

NEUPN/A

VICPN/A

Ticker research

View NEUP research View VICP research

Metric	NEUP Neuphoria Therapeutics Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$18M	$18M
Enterprise Value	$-2M	$18M
Price	$3.36	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	15.45x	0.00x
EV/Sales	-1.44x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.76x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	0.14x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	-92.5%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-779.0%	0.0%
Net Margin (TTM)	-1145.6%	0.0%
FCF Margin (TTM)	-1052.0%	N/A
Net Income (TTM)	$-13M	N/A
FCF (TTM)	$-12M	$0
EPS (TTM)	-$2.49	$0.00
ROE (TTM)	-5591.0%	0.0%
ROA (TTM)	-4222.0%	0.0%
ROIC (TTM)	-5583.0%	0.0%
Financial Health
Cash	$20M	$90K
Debt	$34K	$579K
Net Cash/Debt	$20M	$-489K
Current Ratio (TTM)	27.85x	0.03x
Quick Ratio (TTM)	27.33x	0.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.76	-3.98
52W Performance	-81.7%	-68.9%
YTD Performance	-12.0%	-63.3%
% from 52W High	-82.5%	-68.9%
% from 52W Low	5.3%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-68.1%	0.0%
Earnings Yield (TTM)	-74.1%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,144.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NEUP research	View VICP research

Valuation

P/S Ratio

VICP

0.00x

NEUP

15.45x

EV/FCF

VICP

0.00x

NEUP

0.14x

Growth & revenue

Revenue Growth TTM

NEUP

-92.5%

Forward Revenue Growth

NEUP

0.0%

VICP

0.0%

Profitability & performance

Gross Margin

NEUP

0.0%

VICP

0.0%

ROE

VICP

0.0%

NEUP

-5591.0%

FCF Yield %

VICP

0.0%

NEUP

-68.1%

52-Week Performance

VICP

-68.9%

NEUP

-81.7%

Detailed metrics comparison

NEUP

Neuphoria Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

NEUP$18M

VICP$18M

Enterprise Value

NEUP$-2M

VICP$18M

Price

NEUP$3.36

VICP$0.55

P/E Ratio

NEUPN/A

VICPN/A

P/S Ratio

NEUP15.45x

VICP0.00x

EV/Sales

NEUP-1.44x

VICP0.00x

EV/EBITDA

NEUP0.00x

VICP0.00x

P/B Ratio

NEUP0.76x

VICPN/A

P/FCF Ratio

NEUPN/A

VICPN/A

EV/FCF

NEUP0.14x

VICP0.00x

PEG Ratio

NEUPN/A

VICPN/A

Forward P/E (NTM)

NEUPN/A

VICPN/A

Forward P/S (NTM)

NEUPN/A

VICPN/A

Revenue (TTM)

NEUP$1M

VICP$0

Revenue Growth (YoY)

NEUP-92.5%

VICPN/A

Forward Rev Growth

NEUP0.0%

VICP0.0%

Gross Margin (TTM)

NEUP0.0%

VICP0.0%

Operating Margin (TTM)

NEUP0.0%

VICP0.0%

EBITDA Margin (TTM)

NEUP-779.0%

VICP0.0%

Net Margin (TTM)

NEUP-1145.6%

VICP0.0%

FCF Margin (TTM)

NEUP-1052.0%

VICPN/A

Net Income (TTM)

NEUP$-13M

VICPN/A

FCF (TTM)

NEUP$-12M

VICP$0

EPS (TTM)

NEUP-$2.49

VICP$0.00

ROE (TTM)

NEUP-5591.0%

VICP0.0%

ROA (TTM)

NEUP-4222.0%

VICP0.0%

ROIC (TTM)

NEUP-5583.0%

VICP0.0%

Cash

NEUP$20M

VICP$90K

Debt

NEUP$34K

VICP$579K

Net Cash/Debt

NEUP$20M

VICP$-489K

Current Ratio (TTM)

NEUP27.85x

VICP0.03x

Quick Ratio (TTM)

NEUP27.33x

VICP0.03x

Debt/Equity (TTM)

NEUP0.00x

VICP0.00x

Debt/Assets (TTM)

NEUP0.0%

VICP0.0%

Interest Coverage (TTM)

NEUPN/A

VICPN/A

Net Debt/EBITDA (TTM)

NEUP0.00x

VICP0.00x

Beta

NEUP0.76

VICP-3.98

52W Performance

NEUP-81.7%

VICP-68.9%

YTD Performance

NEUP-12.0%

VICP-63.3%

% from 52W High

NEUP-82.5%

VICP-68.9%

% from 52W Low

NEUP5.3%

VICP399.9%

Asset Turnover (TTM)

NEUP0.04x

VICP0.00x

FCF Yield (TTM)

NEUP-68.1%

VICP0.0%

Earnings Yield (TTM)

NEUP-74.1%

VICP0.0%

Dividend Yield (TTM)

NEUPN/A

VICPN/A

Rule of 40

NEUP-1,144.5

VICP0.0

EV/GP/RG

NEUPN/A

VICPN/A

Ticker research

View NEUP research View VICP research

Metric	NEUP Neuphoria Therapeutics Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$18M	$18M
Enterprise Value	$-2M	$18M
Price	$3.36	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	15.45x	0.00x
EV/Sales	-1.44x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.76x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	0.14x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	-92.5%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-779.0%	0.0%
Net Margin (TTM)	-1145.6%	0.0%
FCF Margin (TTM)	-1052.0%	N/A
Net Income (TTM)	$-13M	N/A
FCF (TTM)	$-12M	$0
EPS (TTM)	-$2.49	$0.00
ROE (TTM)	-5591.0%	0.0%
ROA (TTM)	-4222.0%	0.0%
ROIC (TTM)	-5583.0%	0.0%
Financial Health
Cash	$20M	$90K
Debt	$34K	$579K
Net Cash/Debt	$20M	$-489K
Current Ratio (TTM)	27.85x	0.03x
Quick Ratio (TTM)	27.33x	0.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.76	-3.98
52W Performance	-81.7%	-68.9%
YTD Performance	-12.0%	-63.3%
% from 52W High	-82.5%	-68.9%
% from 52W Low	5.3%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-68.1%	0.0%
Earnings Yield (TTM)	-74.1%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,144.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NEUP research	View VICP research